Drugs were found by recognizing the active ingredient from conventional cures or by serendipitous discovery, similarly as with penicillin. All the more as of late, compound libraries of manufactured little particles, common items or concentrates were screened in intact cells or whole organisms to distinguish substances that had a desirable therapeutic effect in a procedure known as classic pharmacology. Subsequent to sequencing of the human genome permitted fast cloning and combination of enormous amounts of cleaned proteins, it has become regular practice to utilize high throughput screening of huge mixes libraries against detached organic targets which are theorized to be sickness changing in a procedure known as opposite pharmacology. Hits from these screens are then tried in cells and afterward in creatures for adequacy. Glycomics involves the emerging field of glycomics relies upon a diverse set of technologies and strategies, many derived from other emerging fields such as proteomics. Research scientists utilize glycoarrays, high performance liquid chromatography (HPLC), mass spectrometry (MS), databases and libraries of natural glycan and synthetic chemistry.